Welcome to the

European Life Science Journal for international business




Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !

Latest News

2012-05-03

Abbott Laboratories (ABT) Buys AP214 Hormone From Action Pharma for $110 Million

 Abbott (NYSE: ABT) and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.AP214 is in development to prevent acute kidney injury (AKI) associated with major cardiac surgery in patients at increased risk and has further potential in adjacent indications. AP214 is a hormone analogue that tar...
2012-04-23

AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout

 AstraZeneca and Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that they have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego...
2012-04-20

News on the European Cleanroom market

 The specialized cleanroom service company decontam GmbH based in Bad Windsheim near Nürnberghas has, from the 2ndof April 2012, become a part of Berendsen. decontam employs 40people and has b...
2012-04-17

A £180m fund designed to bridge the ‘valley of death’ for medical breakthroughs in the UK will kick off at the end of April

A £180m government scheme designed to support collaboration between innovative SMEs and academics for developing solutions to healthcare challenges will open for applications at the end of April, a...
2012-04-16

Sweden bolsters biotech

 Swedish pharma company Astra Zeneca plus Wallenberg Foundation and Swedish government pledge a record investment into the biotech industry.Stockholm – Under a new initiative, AstraZeneca will...
2012-04-13

Nordic States foster Bioeconomy

 Finland is the last Nordic country which has not yet decided to start a nationwide bioeconomy programme. Calls for such an strategy are becoming louder.Denmark has already implemented a natio...
2012-04-04

AstraZeneca is looking to partner with peers

 After signing a broad licensing deal with Amgen Inc. that involves five experimental compounds, AstraZeneca is looking for partnerships with industry peers. Martin Mackay, head of research at...
2012-03-28

BioChina International 2012-Biopharma and Bioprocessing Congress June 26 and 27 Shanghai, China

 On the way to achieve antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all ...
2012-03-27

A new shortcut for stem cell programming

 Researchers at the University of Bonn artificially derive brain stem cells directly from the connective tissue of miceThese stem cells can reproduce and be converted into various types of bra...
2012-03-26

IMMUNE CELLS WITH A KILLER INSTINCT: TRIED-AND-TESTED ANTI-TUMOUR DRUG DISPLAYS NEW EFFECT

 Imiquimod, a drug used to treat skin cancer, has been shown to have a previously unknown effect on immune cells. The drug transforms cells known as dendritic cells into "tumour killers" that ...